Advertisement
Advertisement
U.S. markets close in 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Agentix Corp. (AGTX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.16510.0000 (0.00%)
As of 12:45PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1651
Open0.1651
BidN/A x N/A
AskN/A x N/A
Day's Range0.1651 - 0.1651
52 Week Range0.1620 - 1.4800
Volume1,200
Avg. Volume1,050
Market Cap6.425M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0680
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AGTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AGENTIX CORP
    Daily – Vickers Top Buyers & Sellers for 05/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    CEO Presenting on the Emerging Growth Conference on February 16 Register Now

    Niche Companies in Technology, Technology, FinTech, Consumer Products, Healthcare, Media, and more in attendanceMIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 25th Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management team

  • Newsfile

    AGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day Podcast

    Phoenix, Arizona--(Newsfile Corp. - January 4, 2022) - The Stock Day Podcast welcomed AGENTIX (OTC Pink: AGTX) ("the Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases including type 2 diabetes mellitus, chronic obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). CEO of the Company, Rudy Mazzocchi, joined Stock Day host Everett Jolly.Jolly began the interview

  • Newsfile

    AGENTIX and RTI International Announce Worldwide Exclusive License and Services Agreement

    New York, New York--(Newsfile Corp. - December 21, 2021) - AGENTIX Corporation (OTC Pink: AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Patent and Know-How License Agreement between the parties, dated October 22, 2021, a worldwide exclusive license and services agreement with Research Triangle Institute, dba RTI International ("RTI"), a nonprofi

Advertisement
Advertisement